Top compounds associated with response to DLST


Feature Type Standardized
Nominal ANOVA
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.023 0.6
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.018 0.6
mRNA elocalcitol CTRPv2 pan-cancer AAC -0.019 0.6
mRNA parbendazole CTRPv2 pan-cancer AAC -0.017 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.6
mRNA BIRB 0796 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA Epothilone B GDSC1000 pan-cancer AAC 0.019 0.6
mRNA Roscovitine GDSC1000 pan-cancer AAC 0.029 0.6
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC 0.04 0.6
Download CSV